News Published: April 8, 2021

VERIGRAFT was selected as a finalist in the 2021 Lyfebulb-CSL Behring Innovation Challenge

Lyfebulb Challenge

Latest news

Published: May 13, 2026

VERIGRAFT Receives CTA Approval for Phase II/III Study of P-TEV

Published: May 7, 2026

VERIGRAFT Q1 2026 – Continued Clinical Progress

Published: April 20, 2026

VERIGRAFT Selected as Finalist in Health Tech Award 2026

Published: March 2, 2026

VERIGRAFT expands its network within advanced therapy applications through EU-funded Doctoral Network VISI-ON-BRAIN

Uncategorized Published: February 12, 2026

VERIGRAFT announces a committed capital contribution of SEK 110 million to advance pivotal trial program in Europe and the US

Uncategorized Published: February 10, 2026

Technology collaboration with South Korea